Cite
Effectiveness of Whole, Inactivated, Low Pathogenicity Influenza A(H7N9) Vaccine against Antigenically Distinct, Highly Pathogenic H7N9 Virus.
MLA
Masato Hatta, et al. “Effectiveness of Whole, Inactivated, Low Pathogenicity Influenza A(H7N9) Vaccine against Antigenically Distinct, Highly Pathogenic H7N9 Virus.” Emerging Infectious Diseases, vol. 24, no. 10, Oct. 2018, pp. 1910–13. EBSCOhost, https://doi.org/10.3201/eid2410.180403.
APA
Masato Hatta, Gongxun Zhong, Shiho Chiba, Lopes, T. J. S., Neumann, G., Yoshihiro Kawaoka, Hatta, M., Zhong, G., Chiba, S., & Kawaoka, Y. (2018). Effectiveness of Whole, Inactivated, Low Pathogenicity Influenza A(H7N9) Vaccine against Antigenically Distinct, Highly Pathogenic H7N9 Virus. Emerging Infectious Diseases, 24(10), 1910–1913. https://doi.org/10.3201/eid2410.180403
Chicago
Masato Hatta, Gongxun Zhong, Shiho Chiba, Tiago J. S. Lopes, Gabriele Neumann, Yoshihiro Kawaoka, Masato Hatta, Gongxun Zhong, Shiho Chiba, and Yoshihiro Kawaoka. 2018. “Effectiveness of Whole, Inactivated, Low Pathogenicity Influenza A(H7N9) Vaccine against Antigenically Distinct, Highly Pathogenic H7N9 Virus.” Emerging Infectious Diseases 24 (10): 1910–13. doi:10.3201/eid2410.180403.